Both in Pharmaceuticals
Hyperion DeFi vs InMed Pharmaceuticals
Over the past year HYPD returned −43.3% and INM returned +405.8%; their daily moves had a correlation of 0.07.
HYPD −43.3% INM +405.8%Growth of $1, one year, split-adjusted
| Metric | HYPD | INM |
|---|---|---|
| Price | $3.07 | $8.75 |
| Market cap | $46.7M | $48.1M |
| Today | +0.66% | +420.83% |
| 1 month | −19.6% | +557.9% |
| 6 months | −15.7% | +1104.6% |
| Year to date | −13.8% | +725.5% |
| 1 year | −48.1% | +373.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | 4009.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 33.3× | 24.8× |
| Net cash | $1.2M | $2.2M |
| Dividend yield | — | — |
| Volatility (60d) | 89.8% | 338.3% |
| Short % of float | 9.0% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).